Medicaid Payer Status, Higher Comorbidity, and Low Income Are Associated With Poorer Outcomes After Total Elbow Arthroplasty
- PMID: 32049897
- DOI: 10.1097/RHU.0000000000001246
Medicaid Payer Status, Higher Comorbidity, and Low Income Are Associated With Poorer Outcomes After Total Elbow Arthroplasty
Abstract
Objective: To assess whether insurance payer, comorbidity, and income are associated with total elbow arthroplasty (TEA) outcomes.
Methods: We used the 1998-2014 US National Inpatient Sample. Multivariable logistic regression adjusted for demographics and underlying diagnosis to estimate odds ratio (OR) and 95% confidence intervals (CI) of insurance payer, comorbidity, and income with TEA outcomes.
Results: The mean age was 60 (SE, 0.29) years, 68% were female, and 62% were white among the 7992 TEA procedures. Compared with private insurance, Medicaid was associated with significantly higher ORs (95% CI) of (1) hospital charges above the median, 1.25 (95% CI, 1.01-1.53); (2) discharge to a rehabilitation facility, 1.64 (95% CI, 1.16-2.31); (3) hospital stay >2 days, 1.63 (95% CI, 1.32-2.00); (4) fracture, 1.71 (95% CI, 1.14-2.56). Medicare payer was associated with higher ORs (95% CI) of (1) discharge to a rehabilitation facility, 1.80 (95% CI, 1.42-2.28); and (2) hospital stay >2 days, 1.29 (95% CI, 1.12-1.50). Compared with Deyo-Charlson score of zero, odds of health care utilization outcomes were higher by 14% to 20% for score of 1 and by 62% to 146% for score of 2 or higher, and by 36% to 257% for transfusion. The lowest income quartile had significantly higher OR of 1.51 (95% CI, 1.31-1.73) of hospital charges above the median versus the highest quartile.
Conclusions: Payer type, comorbidity, and income were associated with higher health care utilization and complications post-TEA. Further investigation into potentially modifiable mediators is needed.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
There are no financial conflicts related directly to this study. J.A.S. has received consultant fees from Crealta/Horizon, Fidia, UBM LLC, Medscape, WebMD, the National Institutes of Health, and the American College of Rheumatology (ACR). J.A.S. owns stock options in Amarin Pharmaceuticals and Viking Therapeutics. J.A.S. is a member of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms-length funding from 36 companies. J.A.S. is a member of the Veterans Affairs Rheumatology Field Advisory Committee. J.A.S. is the editor and the director of the University of Alabama at Birmingham Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis. J.A.S. served as a member of the ACR's Annual Meeting Planning Committee and Quality of Care Committees; the chair of the ACR Meet-the-Professor, Workshop and Study Group Subcommittee; and the cochair of the ACR Criteria and Response Criteria subcommittee. J.D.C. declares no conflict of interest.
Similar articles
-
Age, race, comorbidity, and insurance payer type are associated with outcomes after total ankle arthroplasty.Clin Rheumatol. 2020 Mar;39(3):881-890. doi: 10.1007/s10067-019-04826-5. Epub 2019 Nov 18. Clin Rheumatol. 2020. PMID: 31741131
-
Medicaid or Medicare insurance payer status and household income are associated with outcomes after primary total hip arthroplasty.Clin Rheumatol. 2018 Sep;37(9):2489-2496. doi: 10.1007/s10067-018-4126-y. Epub 2018 May 3. Clin Rheumatol. 2018. PMID: 29721713
-
Socioeconomic status and healthcare access are associated with healthcare utilization after knee arthroplasty: A U.S. national cohort study.Joint Bone Spine. 2020 Mar;87(2):157-162. doi: 10.1016/j.jbspin.2019.11.007. Epub 2019 Dec 4. Joint Bone Spine. 2020. PMID: 31811933
-
Insurance Payer Type and Patient Income Are Associated with Outcomes after Total Shoulder Arthroplasty.J Rheumatol. 2020 Apr;47(4):589-596. doi: 10.3899/jrheum.190287. Epub 2019 Jun 1. J Rheumatol. 2020. PMID: 31154417 Free PMC article.
-
Abdominal Aortic Aneurysm Repair Readmissions and Disparities of Socioeconomic Status: A Multistate Analysis, 2007-2014.J Cardiothorac Vasc Anesth. 2019 Oct;33(10):2737-2745. doi: 10.1053/j.jvca.2019.03.020. Epub 2019 Mar 14. J Cardiothorac Vasc Anesth. 2019. PMID: 31064731 Review.
Cited by
-
Implant survival of total elbow arthroplasty: analysis of 514 cases from the Dutch Arthroplasty Registry.Bone Jt Open. 2023 Feb 21;4(2):110-119. doi: 10.1302/2633-1462.42.BJO-2022-0152.R1. Bone Jt Open. 2023. PMID: 37051858 Free PMC article.
-
Medicare and Medicaid patients undergoing total joint arthroplasty have more complications and healthcare utilization than privately insured patients.J Orthop. 2024 Nov 8;59:137-143. doi: 10.1016/j.jor.2024.10.040. eCollection 2025 Jan. J Orthop. 2024. PMID: 39635422
-
Prognostic factors associated with failure of total elbow arthroplasty.Bone Joint Res. 2024 May 1;13(5):201-213. doi: 10.1302/2046-3758.135.BJR-2023-0281.R1. Bone Joint Res. 2024. PMID: 38688503 Free PMC article.
References
-
- Angst F, John M, Pap G, et al. Comprehensive assessment of clinical outcome and quality of life after total elbow arthroplasty. Arthritis Rheum . 2005;53:73–82.
-
- Day JS, Lau E, Ong KL, et al. Prevalence and projections of total shoulder and elbow arthroplasty in the United States to 2015. J Shoulder Elbow Surg . 2010;19:1115–1120.
-
- Singh JA, Ramachandran R. Sex differences in characteristics, utilization, and outcomes of patient undergoing total elbow arthroplasty: a study of the US nationwide inpatient sample. Clin Rheumatol . 2016;35:723–731.
-
- Li X, Veltre DR, Cusano A, et al. Insurance status affects postoperative morbidity and complication rate after shoulder arthroplasty. J Shoulder Elbow Surg . 2017;26:1423–1431.
-
- Smucny M, Menendez ME, Ring D, et al. Inpatient surgical site infection after shoulder arthroplasty. J Shoulder Elbow Surg . 2015;24:747–753.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical